SSTR5 and pancreatic neoplasm: SSTR5 is a proven anti-proliferation receptor in pancreatic cells, Previous studies have reported that the SSTR5 agonist somatostatin analogue AN-238 can significantly inhibit the proliferation of pancreatic cancer cells in vitro and in vivo [25].